Table 5 Study variables positively and negatively correlated with SARS-COV-2 positivity
Positive linear correlation | |||
VARIABLES | Pearson R | VARIABLES | Pearson R |
*Fever | 0.33 | *Sinus Rhythm | 0.06 |
*Body temperature (degree Celsius) | 0.27 | *Chronic kidney disease | 0.05 |
Lymphocytes percentage | 0.26 | *Monocytes percentage | 0.05 |
Cough | 0.22 | Hypertension | 0.04 |
*Total red blood cells count (106/μL) | 0.19 | Asthma | 0.04 |
*Haemoglobin (g/dL) | 0.17 | *Age | 0.04 |
Glasgow coma scale (GCS) | 0.17 | Gastrointestinal symptoms | 0.04 |
*Antibiotics before Emergency Department | 0.16 | *Calcium channel antagonist | 0.04 |
*Chest pain | 0.15 | Mean corpuscular haemoglobin concentration (%) | 0.03 |
*Chest X-rays opacity | 0.14 | Respiratory rate (breaths/min) | 0.03 |
*Sartans | 0.13 | *Female | 0.02 |
*Systolic blood pressure (mmHg) | 0.12 | *Headache | 0.02 |
Haematocrit (%) | 0.12 | *Immunosuppressant drugs | 0.02 |
Arthralgia | 0.09 | *Hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitors | 0.02 |
*Diastolic blood pressure (mmHg) | 0.07 | Hematologic malignancy | 0.02 |
P wave present and normal | 0.07 | *Angiotensin converting enzyme inhibitor | 0.01 |
*5-alpha-reductase inhibitors | 0.07 | Heart rate (beats per minute) | 0.00 |
Chronic Interstitial lung disease | 0.06 | Â | Â |
Negative linear correlation | |||
VARIABLES | Pearson R | VARIABLES | Pearson R |
*Total white blood cells count (103/μL) | −0.46 | *Dyspnoea | −0.07 |
*Eosinophils percentages | −0.34 | *Ischemic cardiomyopathy | −0.06 |
Platelets (103/μL) | − 0.33 | *Basophils percentage | − 0.06 |
*Anti-epileptic therapy | −0.25 | Diabetes mellitus | −0.06 |
*Calcium (mg/dL) | −0.22 | Creatinine (mg/dL) | −0.06 |
Mean red blood cell volume (μm3) | −0.21 | *Mean corpuscular haemoglobin (pg) | −0.06 |
Neutrophils percentages | −0.19 | *Non Invasive Ventilation | −0.05 |
*Drugs for psychiatric disorders | −0.19 | Autoimmune/inflammatory disease | −0.04 |
*Chest X-rays pleural effusion | −0.19 | Red blood cells distribution width (%) | −0.04 |
*Chronic obstructive pulmonary disease | −0.17 | Anti-arrhythmic drugs | −0.04 |
*Smoking (active) | −0.15 | Syncope | −0.04 |
*Urea (mg/dL) | −0.14 | Glycaemia (mg/dL) | −0.03 |
*Total bilirubin (mg/dL) | −0.14 | *Diuretics | −0.03 |
Oxygen supplementation | −0.11 | Atrial fibrillation | −0.03 |
*Solid organ tumour | −0.11 | C-reactive protein (mg/dL) | −0.03 |
*Sore throat | −0.10 | *Male | −0.02 |
Human Immunodeficiency Virus | −0.09 | Beta blocker | −0.02 |
Asthenia | −0.08 | Anticoagulant therapy | −0.02 |
Chronic liver disease | −0.08 | *Anti-platelets therapy | −0.02 |
*Sodium (mEq/L) | −0.07 |  |  |